ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
533 hedge funds and large institutions have $25.4B invested in Alexion Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 224 increasing their positions, 176 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $30.2B → $25.4B (-$4.75B)
19% less call options, than puts
Call options by funds: $155M | Put options by funds: $192M
Holders
533
Holding in Top 10
16
Calls
$155M
Puts
$192M
Top Buyers
| 1 | +$234M | |
| 2 | +$158M | |
| 3 | +$130M | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$89M |
| 5 |
ClearBridge Investments
New York
|
+$86.4M |
Top Sellers
| 1 | -$989M | |
| 2 | -$883M | |
| 3 | -$363M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$235M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$114M |